These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 2903093

  • 1. Ovarian function after the menarche and hormonal contraception.
    Borsos A, Lampé L, Balogh A, Csoknyay J, Ditròi F, Székely P.
    Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
    [Abstract] [Full Text] [Related]

  • 2. Ovarian function immediately after the menarche.
    Borsos A, Lampé LG, Balogh A, Csoknyay J, Ditroi F.
    Int J Gynaecol Obstet; 1986 Jun; 24(3):239-42. PubMed ID: 2880764
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 4. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study.
    Peña AS, Doherty DA, Atkinson HC, Hickey M, Norman RJ, Hart R.
    Arch Dis Child; 2018 Mar; 103(3):235-239. PubMed ID: 28794095
    [Abstract] [Full Text] [Related]

  • 5. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF, Vigil P, Cooke DG, d'Arcangues C, Brown JB.
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [Abstract] [Full Text] [Related]

  • 6. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB, Holmes J, Barker G.
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [Abstract] [Full Text] [Related]

  • 7. Mean versus individual hormonal profiles in the menstrual cycle.
    Alliende ME.
    Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
    [Abstract] [Full Text] [Related]

  • 8. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 9. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 10. Symptothermal and hormonal markers of potential fertility in climacteric women.
    Flynn AM, James P, Collins WP, Royston P.
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
    [Abstract] [Full Text] [Related]

  • 11. A pilot study on the utility of reduced urine collection frequency protocols for the assessment of reproductive hormones in adolescent girls.
    Allaway HCM, John EM, Keegan TH, De Souza MJ.
    J Pediatr Endocrinol Metab; 2017 Oct 26; 30(10):1083-1093. PubMed ID: 28949930
    [Abstract] [Full Text] [Related]

  • 12. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.
    Am J Obstet Gynecol; 1995 Sep 26; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [Abstract] [Full Text] [Related]

  • 13. Menstrual Patterns in the First Gynecological Year: A Systematic Review.
    Gunn HM, Tsai MC, McRae A, Steinbeck KS.
    J Pediatr Adolesc Gynecol; 2018 Dec 26; 31(6):557-565.e6. PubMed ID: 30064002
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF, Vigil P, Alliende ME, Brown S, Festin M, Cooke DG.
    Hum Reprod; 2016 Feb 26; 31(2):445-53. PubMed ID: 26677961
    [Abstract] [Full Text] [Related]

  • 15. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.
    Jay N, Mansfield MJ, Blizzard RM, Crowley WF, Schoenfeld D, Rhubin L, Boepple PA.
    J Clin Endocrinol Metab; 1992 Sep 26; 75(3):890-4. PubMed ID: 1517382
    [Abstract] [Full Text] [Related]

  • 16. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A.
    Metabolism; 1991 Aug 26; 40(8):849-54. PubMed ID: 1907348
    [Abstract] [Full Text] [Related]

  • 17. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL.
    Am J Obstet Gynecol; 1997 Jun 26; 176(6):1376-80. PubMed ID: 9215201
    [Abstract] [Full Text] [Related]

  • 18. Body weight and the initiation of puberty.
    Baker ER.
    Clin Obstet Gynecol; 1985 Sep 26; 28(3):573-9. PubMed ID: 4053451
    [Abstract] [Full Text] [Related]

  • 19. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP, Collins PO, Kilpatrick MJ, Manning PA, Pike JM, Tyler JP.
    Acta Endocrinol (Copenh); 1979 Feb 26; 90(2):336-48. PubMed ID: 419920
    [Abstract] [Full Text] [Related]

  • 20. Ovulatory status and menstrual cycle duration assessed by self-collection of urine on pH strips in a population-based sample of French women not using hormonal contraception.
    Rosetta L, Thalabard JC, Tanniou J, Ducot B, Maitrot-Mantelet L, Rousset-Jablonski C, Bohet A, Bouyer J, Chimenes A, Slama R.
    Eur J Contracept Reprod Health Care; 2017 Dec 26; 22(6):450-458. PubMed ID: 29260590
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.